Fellermann K - Search Results

1

Probiotic E. coli treatment mediates antimicrobial human beta-defensin synthesis and fecal excretion in humans.

Möndel M, Schroeder BO, Zimmermann K, Huber H, Nuding S, Beisner J, Fellermann K, Stange EF, Wehkamp J. Möndel M, et al. Among authors: fellermann k. Mucosal Immunol. 2009 Mar;2(2):166-72. doi: 10.1038/mi.2008.77. Epub 2008 Nov 26. Mucosal Immunol. 2009. PMID: 19129752 Free PMC article.

2

Mevinolin, a competitive inhibitor of hydroxymethylglutaryl coenzyme A reductase, suppresses enterocyte esterification of exogenous but not endogenous cholesterol.

Fellermann K, Reimann FM, Herold G, Stange EF. Fellermann K, et al. Biochim Biophys Acta. 1992 Nov 11;1165(1):78-83. doi: 10.1016/0005-2760(92)90078-a. Biochim Biophys Acta. 1992. PMID: 1420351

3

Reduced cholesterol esterification in CaCo-2 cells by indirect action of pravastatin.

Reimann FM, Winkelmann F, Fellermann K, Stange EF. Reimann FM, et al. Among authors: fellermann k. Atherosclerosis. 1996 Aug 23;125(1):63-70. doi: 10.1016/0021-9150(96)05848-0. Atherosclerosis. 1996. PMID: 8831928

4

Crohn's disease and sarcoidosis: systemic granulomatosis?

Fellermann K, Stahl M, Dahlhoff K, Amthor M, Ludwig D, Stange EF. Fellermann K, et al. Eur J Gastroenterol Hepatol. 1997 Nov;9(11):1121-4. doi: 10.1097/00042737-199711000-00018. Eur J Gastroenterol Hepatol. 1997. PMID: 9431906

5

Intestinal expression of human heat shock protein 90 in patients with Crohn's disease and ulcerative colitis.

Stahl M, Ludwig D, Fellermann K, Stange EF. Stahl M, et al. Among authors: fellermann k. Dig Dis Sci. 1998 May;43(5):1079-87. doi: 10.1023/a:1018847205420. Dig Dis Sci. 1998. PMID: 9590425

6

Steroid-unresponsive acute attacks of inflammatory bowel disease: immunomodulation by tacrolimus (FK506).

Fellermann K, Ludwig D, Stahl M, David-Walek T, Stange EF. Fellermann K, et al. Am J Gastroenterol. 1998 Oct;93(10):1860-6. doi: 10.1111/j.1572-0241.1998.539_g.x. Am J Gastroenterol. 1998. PMID: 9772045

7

Mesenteric blood flow is related to disease activity and risk of relapse in ulcerative colitis: a prospective follow up study.

Ludwig D, Wiener S, Brüning A, Schwarting K, Jantschek G, Fellermann K, Stahl M, Stange EF. Ludwig D, et al. Among authors: fellermann k. Gut. 1999 Oct;45(4):546-52. doi: 10.1136/gut.45.4.546. Gut. 1999. PMID: 10486363 Free PMC article.

8

Enhanced intestinal expression of heat shock protein 70 in patients with inflammatory bowel diseases.

Ludwig D, Stahl M, Ibrahim ET, Wenzel BE, Drabicki D, Wecke A, Fellermann K, Stange EF. Ludwig D, et al. Among authors: fellermann k. Dig Dis Sci. 1999 Jul;44(7):1440-7. doi: 10.1023/a:1026616221950. Dig Dis Sci. 1999. PMID: 10489932

9

Mycophenolate mofetil: lack of efficacy in chronic active inflammatory bowel disease.

Fellermann K, Steffen M, Stein J, Raedler A, Hämling J, Ludwig D, Loeschke K, Stange EF. Fellermann K, et al. Aliment Pharmacol Ther. 2000 Feb;14(2):171-6. doi: 10.1046/j.1365-2036.2000.00695.x. Aliment Pharmacol Ther. 2000. PMID: 10651657 Free article. Clinical Trial.

10

Chronic hepatitis C, common variable immunodeficiency and autoimmune hemolytic anemia. Coincidence by chance or common etiology?

Fellermann K, Stange EF. Fellermann K, et al. Hepatogastroenterology. 2000 Sep-Oct;47(35):1422-4. Hepatogastroenterology. 2000. PMID: 11100366

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

123 results

Search Page

Filters